[Vaccinovigilance: Adverse reaction reports of animal vaccines in 2020].

Zaugg, I.; Ottiger, H. P. (2021). [Vaccinovigilance: Adverse reaction reports of animal vaccines in 2020]. Schweizer Archiv für Tierheilkunde, 163(9), pp. 545-552. Gesellschaft Schweizer Tierärztinnen und Tierärzte 10.17236/sat00312

[img]
Preview
Text
SAT_9_2021_Ottiger_02.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (271kB) | Preview

The aim of the vigilance system in Switzerland is the evaluation and classification of reported suspected adverse reactions of immunological veterinary medicines (IVMP), including suspected lack of expected efficacy. The Institute of Virology and Immunology (IVI) is the competent authority for marketing authorizations of immunological veterinary medicinal products in Switzerland and responsible for the vaccinovigilance system. In 2020, 130 adverse reaction reports were received (5% less compared to 2019). The reports mainly concerned dogs (41%) and cats (25%) followed by cattle (18%) and horses (7%). Many of the reports in dogs involved the application of combined vaccines against canine distemper, hepatitis, parvovirosis and parainfluenza in combination with canine leptospira components, in cats against cat flu and feline panleukopenia in combination with feline leukaemia virus infection. Causality assessments were done according to the international ABON system. In 27% of the reported cases, the causality assessments between the vaccination and the reaction described were evaluated as being probable (ABON A), in 44% as possible (ABON B).

Item Type:

Journal Article (Review Article)

Division/Institute:

05 Veterinary Medicine > Department of Infectious Diseases and Pathobiology (DIP) > Institute of Virology and Immunology

Subjects:

500 Science
500 Science > 570 Life sciences; biology
500 Science > 590 Animals (Zoology)
600 Technology > 610 Medicine & health
600 Technology > 630 Agriculture

ISSN:

1664-2848

Publisher:

Gesellschaft Schweizer Tierärztinnen und Tierärzte

Language:

German

Submitter:

Katharina Gerber-Paizs

Date Deposited:

08 Mar 2022 14:44

Last Modified:

10 Jun 2022 09:19

Publisher DOI:

10.17236/sat00312

PubMed ID:

34465558

Uncontrolled Keywords:

IVI Impfstoff Pharmakovigilanz Sicherheit Vaccin Vaccine Vaccino Wirksamkeit adverse reaction effet indésirable efficacia efficacité efficacy pharmacovigilance reazioni avverse ai farmaci safety sicurezza sécurité unerwünschte Arzneimittelwirkungen ­farmacovigilanza

BORIS DOI:

10.48350/165657

URI:

https://boris.unibe.ch/id/eprint/165657

Actions (login required)

Edit item Edit item
Provide Feedback